LENZ Therapeutics LENZ
NASDAQ LENZ
$3.82 -0.04 (-1.09%)
As of: Sep 30, 2026 · 10:07 AM EDT

LENZ Therapeutics (LENZ) Gross Margin (2025 - 2026)

Updated

LENZ Therapeutics (LENZ) recorded Gross Margin of 94.90% in Q2 2026, down 5.10 percentage points from 100.00% a year earlier but up 51.50 percentage points from the prior quarter.

Analysis

LENZ Therapeutics (LENZ) Gross Margin (2025 - 2026) Analysis & Trends

On a TTM basis, LENZ Therapeutics' Gross Margin came in at 51.37% as of Jun 30, 2026; for FY2025, it was 97.81%.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Gross Margin (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 68.19%
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 74.74%
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 73.54%
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 78.02%
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn 83.60%
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 72.04%
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 79.76%
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 72.78%
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 85.33%
10 LENZ Therapeutics 124.41 Mn 124.41 Mn 5.21 Mn 94.90%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 94.90%
Mar 31, 2026 43.40%
Jun 30, 2025 100.00%
API Access

LENZ Therapeutics Gross Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=gross-margin&ticker=LENZ&period=max&api_key=YOUR_API_KEY